A modified ultrarush insect venom immunotherapy protocol for children

Allergy and Asthma Proceedings

Volumn 27, Issue 2, 2006, Pages 148-150

  Steiss, Jens Oliver ^a,b   Jödicke, Birgit ^a   Lindemann, Hermann ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b Department of Pediatrics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEE VENOM; WASP VENOM;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DESENSITIZATION; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MALE; METHODOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; TIME;

ADOLESCENT; BEE VENOMS; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; PROSPECTIVE STUDIES; TIME FACTORS; WASP VENOMS;

EID: 33646486145     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Birnbaum J, Ramadour M, Magnan A, and Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): A safety study and risk factors. Clin Exp Allergy 33:58-64, 2003.
2. Brehler R, Wolf H, Kütting B, et al. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 105:1231-1235, 2000.
3. Rueff F, Przybilla B, and Müller U. The sting challenge test in Hymenoptera venom allergy. Allergy 51:216-225, 1996.
4. Michils A, Baldassarre S, Ledent C, et al. Early effect of ultrarush venom immunotherapy on the IgG antibody response. Allergy 55:455-462, 2000.
5. Schiavino D, Nucera E, Pollastrini E, et al. Specific ultrarush desensitization in Hymenoptera venom-allergic patients. Ann Allergy Asthma Immunol 92:409-413, 2004.
6. Sturm G, Kränke B, Rudolph C, and Aberer W. Rush Hymenoptera venom immunotherapy: A safe and practical protocol for high-risk patients. J Allergy Clin Immunol 110:928-933, 2002.
7. Wenzel J, Meissner-Kraemer M, Bauer R, et al. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy 58:1176-1179, 2003.
8. van der Zwan JC, Flinterman J, Jankowski IG, and Kerckhaert JA. Hyposensitisation to wasp venom in six hours. Br Med J 287:1329-1331, 1983.
9. Müller U, and Mosbech H. Position paper: Immunotherapy with Hymenoptera venoms. Allergy 48(suppl):37-46, 1996.
10. Mueller HL. Diagnosis and treatment of insect sensitivity. Asthma Res 3:331-333, 1966.
11. Brockow K, Kiehn M, and Riethmuller C. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomised, placebo-controlled trial. J Allergy Clin Immunol 100:458-463, 1997.
12. Reimers A, Hari Y, and Müller U. Reduction of side-effects from ultrarush immunotherapy with bee venom by pre-treatment with fexofenadine: A double-blind, placebo-controlled trial. Allergy 55:484-488, 2000.
13. Scribner TA, and Bernstein DI. Rapid venom immunotherapy update. Curr Opin Allergy Clin Immunol 3:295-298, 2003.
14. Schuetze GE, Forster J, Hauk PJ, et al. Bee-venom allergy in children: Long-term predictive value of standardized challenge tests. Pediatr Allergy Immunol 13:18-23, 2002.
15. Rueff F, Wenderoth A, and Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 108:1027-1032, 2001.